The FDA has several major concerns about data Johnson & Johnson (JNJ +0.3%) submitted in a...

|About: Johnson & Johnson (JNJ)|By:, SA News Editor

The FDA has several major concerns about data Johnson & Johnson (JNJ +0.3%) submitted in a bid to win approval for expanded use of its Doribax antibiotic.